3D Laparoscopic Adrenalectomies for Adrenal Tumors

Launched by INSTITUT D'INVESTIGACIÓ BIOMÈDICA DE GIRONA DR. JOSEP TRUETA · May 26, 2021

Keywords

ClinConnect Summary

This clinical trial is studying a new type of surgery called 3D laparoscopic adrenalectomy, which is used to remove tumors from the adrenal glands. Traditional laparoscopic surgery uses 2D images, which can make it hard for surgeons to see depth and orientation during the procedure. The researchers believe that using a 3D system may help improve surgical outcomes, making the surgery safer and more effective.

To participate in this trial, you need to be an adult aged 18 or older who has been diagnosed with adrenal tumors, whether they are benign (non-cancerous) or malignant (cancerous). The surgery will be performed if you are undergoing a unilateral (one-sided) adrenalectomy, and you will need to have a follow-up for at least 30 days after the surgery. If you have had emergency surgery, open surgery, or other specific procedures, you may not be eligible. Participants can expect to be part of an important study that could improve how adrenal tumors are treated in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • All adult patients (age ≥ 18 years)
• • Patients diagnosed with adrenal masses (benign and malignant tumors)
• • Underwent a unilateral 3D laparoscopic adrenalectomy from January 2013 to December 2033.
• Exclusion Criteria:
• • Emergency surgery.
• • Open adrenalectomy.
• • Bilateral adrenalectomies (open or laparoscopy).
• • Patients who underwent laparoscopic adrenalectomy together with another laparoscopic surgical procedure in the same intervention.
• • Patients without complete follow-up for at least 30 days after hospital discharge.